UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies

Autoimmunity reviews, 2016-02, Vol.15 (2), p.113-123

Sternberg, Zohara

2016

Link zum Volltext

Verfügbarkeit prüfen

Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy

Current pharmaceutical design, 2012-04, Vol.18 (12), p.1635

Sternberg, Zohara

2012

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration

Neuromolecular medicine, 2018-03, Vol.20 (1), p.37-53

Sternberg, Zohara

2018

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients

CNS & neurological disorders drug targets, 2013-02, Vol.12 (1), p.104

2013

Link zum Volltext

Verfügbarkeit prüfen

Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities

Molecular neurobiology, 2017, Vol.54 (1), p.362-374

Sternberg, Zohara

2017

Link zum Volltext

Verfügbarkeit prüfen

Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression

Immunobiology (1979), 2016-02, Vol.221 (2), p.193-198

2016

Link zum Volltext

Verfügbarkeit prüfen

Photic sneeze reflex: another variant of the trigeminocardiac reflex?

Future neurology, 2019-11, Vol.14 (4)

2019

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood

Atherosclerosis, 2013-08, Vol.229 (2), p.338-347

2013

Link zum Volltext

Verfügbarkeit prüfen

Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D3 , and Epstein-Barr virus

Autoimmunity reviews, 2012-12, Vol.12 (2), p.250-259

Sternberg, Zohara

2012

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis

Journal of neuroinflammation, 2010-10, Vol.7 (1), p.72-72

2010

Link zum Volltext

Verfügbarkeit prüfen

Chronic Cerebrospinal Venous Insufficiency: Is It Venosclerosis?

Journal of endovascular therapy, 2015-08, Vol.22 (4), p.647-649

Sternberg, Zohara

2015

Link zum Volltext

Verfügbarkeit prüfen

Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke

Journal of stroke and cerebrovascular diseases, 2016-02, Vol.25 (2), p.327-334

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis

Neuromolecular medicine, 2016-03, Vol.18 (1), p.16-36

Sternberg, Zohara

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta

Journal of neuroinflammation, 2009-10, Vol.6 (1), p.28-28

2009

Link zum Volltext

Verfügbarkeit prüfen

Transvascular Autonomic Modulation: A Modified Balloon Angioplasty Technique for the Treatment of Autonomic Dysfunction in Multiple Sclerosis Patients

Journal of endovascular therapy, 2014-06, Vol.21 (3), p.417-428

2014

Link zum Volltext

Verfügbarkeit prüfen

Mechanical ventilation down-regulates surfactant protein a and keratinocyte growth factor expression in premature rabbits

Pediatric research, 2007-09, Vol.62 (3), p.277-282

2007

Link zum Volltext

Verfügbarkeit prüfen

Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen

Journal of stroke and cerebrovascular diseases, 2013-08, Vol.22 (6), p.725-732

2013

Link zum Volltext

Verfügbarkeit prüfen

Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients

Neuropharmacology, 2018-03, Vol.130, p.71-76

2018

Link zum Volltext

Verfügbarkeit prüfen

Elevated spermidine serum levels in mild cognitive impairment, a potential biomarker of progression to Alzheimer dementia, a pilot study

Journal of clinical neuroscience, 2022-06, Vol.100, p.169-174

2022

Link zum Volltext

Verfügbarkeit prüfen

Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis

Cardiovascular therapeutics, 2014-04, Vol.32 (2), p.33-39

2014

Link zum Volltext

Verfügbarkeit prüfen

Increased free prostate specific antigen serum levels in Alzheimer's disease, correlation with Cognitive Decline

Journal of the neurological sciences, 2019-05, Vol.400, p.188-193

2019

Link zum Volltext

Verfügbarkeit prüfen

High-mobility group box 1 in multiple sclerosis

Immunologic research, 2016-04, Vol.64 (2), p.385-391

2016

Link zum Volltext

Verfügbarkeit prüfen

Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis

Journal of neuroimmunology, 2014-09, Vol.274 (1), p.197-201

2014

Link zum Volltext

Verfügbarkeit prüfen

Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease

Aging and disease, 2017-04, Vol.8 (2), p.215-227

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects

Atherosclerosis, 2013-12, Vol.231 (2), p.411-420

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)
Dissertationen
(1)

Sprache

Englisch
(37)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies

Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy

Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration

The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients

Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities

Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression

Photic sneeze reflex: another variant of the trigeminocardiac reflex?

Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood

Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D3 , and Epstein-Barr virus

Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis

Chronic Cerebrospinal Venous Insufficiency: Is It Venosclerosis?

Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke

Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta

Transvascular Autonomic Modulation: A Modified Balloon Angioplasty Technique for the Treatment of Autonomic Dysfunction in Multiple Sclerosis Patients

Mechanical ventilation down-regulates surfactant protein a and keratinocyte growth factor expression in premature rabbits

Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen

Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients

Elevated spermidine serum levels in mild cognitive impairment, a potential biomarker of progression to Alzheimer dementia, a pilot study

Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis

Increased free prostate specific antigen serum levels in Alzheimer's disease, correlation with Cognitive Decline

High-mobility group box 1 in multiple sclerosis

Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis

Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease

Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects

Suchergebnisse filtern